Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)

NCT05036005 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Breast Neoplasms
Breast Cancer Female
HER2-positive Breast Cancer

Interventions

DRUG: Ontruzant
DRUG: Chemotherapy
DRUG: Pertuzumab

Sponsor

Institut fuer Frauengesundheit

Collaborators

[object Object]